David Lally to Follow-Up Studies
This is a "connection" page, showing publications David Lally has written about Follow-Up Studies.
Connection Strength
0.413
-
Choi H, Corradetti G, Lindenberg S, Karamat AN, Oncel D, Liu H, Gnanaraj R, Fasih-Ahmad S, Marion KM, Baker KL, Gulati S, Foster B, Lam A, Sadda SR, Lally DR. Incomplete RPE and Outer Retinal Atrophy (iRORA) Development in Eyes With Fellow-eye Neovascular Age-related Macular Degeneration. Ophthalmic Surg Lasers Imaging Retina. 2025 05; 56(5):274-279.
Score: 0.149
-
Lally DR, Kasetty MA. CLOSURE OF SMALL MACULAR HOLES USING VITRECTOMY SURGERY WITH INTERNAL LIMITING MEMBRANE PEELING WITHOUT THE USE OF INTRAOCULAR GAS TAMPONADE: BROADENING THE UNDERSTANDING OF THE MACULAR HOLE PATHOPHYSIOLOGY. Retin Cases Brief Rep. 2020; 14(2):104-109.
Score: 0.105
-
Lally DR, Baumal C. Subretinal drusenoid deposits associated with complement-mediated IgA nephropathy. JAMA Ophthalmol. 2014 Jun; 132(6):775-7.
Score: 0.071
-
Khanani AM, Danzig CJ, Heier JS, Jaffe GJ, Kaiser PK, Lally DR, Patel SS, Vajzovic L, Weng CY, Patel H, Clark J, Desai D, Luo D, Henry E, Holz FG. Avacincaptad Pegol for Geographic Atrophy Secondary to Age-Related Macular Degeneration: Two-Year Efficacy and Safety Results from the GATHER2 Phase 3 Trial. Ophthalmology. 2026 04; 133(4):451-465.
Score: 0.040
-
Danzig CJ, Khanani AM, Kaiser PK, Chang MA, Kovach JL, Lally DR, Rachitskaya A, Sheth VS, Vajzovic L, Clark J, Tang J, Zhu L, Desai D, Chakravarthy U. Vision Loss Reduction with Avacincaptad Pegol for Geographic Atrophy: A 12-Month Post Hoc Analysis of the GATHER1 and GATHER2 Trials. Ophthalmol Retina. 2024 11; 8(11):1052-1060.
Score: 0.035
-
Shields CL, Furuta M, Thangappan A, Nagori S, Mashayekhi A, Lally DR, Kelly CC, Rudich DS, Nagori AV, Wakade OA, Mehta S, Forte L, Long A, Dellacava EF, Kaplan B, Shields JA. Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes. Arch Ophthalmol. 2009 Aug; 127(8):989-98.
Score: 0.013